These symptoms are usually mild but can be uncomfortable for those who experience them
Many patients prefer it as a gentler, more sustainable option
BPC-157 is not on the FDA's approved drug list, but the bulk active ingredient is permitted for compounding by a 503A pharmacy under Section 503A of the Federal Food, Drug, and Cosmetic Act
Phase I data and clinical experience report no serious adverse events at doses up to 10 mg per injection
[124] Other causes of B 12 malabsorption include bariatric surgery, pancreatic insufficiency, obstructive jaundice, tropical sprue, celiac disease, inherited intrinsic factor deficiency, and radiation enteritis affecting the distal ileum